ROCKWELL MEDICAL, INC. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-30: Form DEF 14A; Period of report 2026-04-30; Description DEF 14A; Document rmti-20260428.htm.
- 2025-04-14: Form DEF 14A; Period of report 2025-05-20; Description DEF 14A; Document ny20041335x1_def14a.htm.
- 2024-04-15: Form DEF 14A; Period of report 2024-05-21; Description DEF 14A; Document ny20019207x1_def14a.htm.
- 2023-04-17: Form DEF 14A; Period of report 2023-05-23; Description DEF 14A; Document ny20008260x1_def14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-30 | DEF 14A | 2026-04-30 | DEF 14A | rmti-20260428.htm |
| 2025-04-14 | DEF 14A | 2025-05-20 | DEF 14A | ny20041335x1_def14a.htm |
| 2024-04-15 | DEF 14A | 2024-05-21 | DEF 14A | ny20019207x1_def14a.htm |
| 2023-04-17 | DEF 14A | 2023-05-23 | DEF 14A | ny20008260x1_def14a.htm |
| 2022-04-08 | DEF 14A | 2022-05-09 | DEF14A | tm229838-5_def14a.htm |
| 2021-04-30 | DEF 14A | 2021-06-17 | DEF 14A | rmti-20210617xdef14a.htm |
| 2020-04-20 | DEF 14A | 2020-05-18 | DEF 14A | rmti-20200518xdef14a.htm |
| 2019-04-30 | DEF 14A | 2019-06-06 | DEF 14A | a2238618zdef14a.htm |
| 2018-04-30 | DEF 14A | 2018-06-21 | DEF 14A | a2235270zdef14a.htm |
| 2016-04-18 | DEF 14A | 2016-06-02 | DEF 14A | a2228267zdef14a.htm |
| 2015-04-13 | DEF 14A | 2015-05-21 | DEF 14A | a2224193zdef14a.htm |
| 2014-04-14 | DEF 14A | 2014-05-22 | DEF 14A | a2219543zdef14a.htm |
| 2013-03-29 | DEF 14A | 2013-04-30 | DEF 14A | a2214089zdef14a.htm |
| 2012-04-13 | DEF 14A | 2012-05-24 | DEF 14A | d331484ddef14a.htm |
| 2011-04-15 | DEF 14A | 2011-05-26 | DEF 14A | k50275ddef14a.htm |
| 2010-04-15 | DEF 14A | 2010-05-27 | DEF 14A | k49090def14a.htm |
| 2009-04-20 | DEF 14A | 2009-05-21 | FORM DEF 14A | k47614ddef14a.htm |
| 2008-04-18 | DEF 14A | 2008-05-23 | DEFINITIVE PROXY STATEMENT | k25423ddef14a.htm |
| 2007-04-18 | DEF 14A | 2007-05-24 | DEFINITIVE PROXY STATEMENT | k14105ddef14a.htm |
| 2006-04-17 | DEF 14A | 2006-05-25 | DEFINITIVE PROXY STATEMENT | k04141ddef14a.txt |
| 2005-04-21 | DEF 14A | 2005-05-26 | DEFINITIVE PROXY STATEMENT | k91735def14a.txt |
| 2004-04-23 | DEF 14A | 2004-05-27 | DEFINITIVE PROXY STATEMENT | k83534def14a.txt |
| 2003-04-22 | DEF 14A | 2003-05-27 | DEFINITIVE PROXY STATEMENT | k75008def14a.txt |
| 2002-04-30 | DEF 14A | 2002-06-04 | DEFINITIVE PROXY STATEMENT | k69149def14a.txt |
| 2001-04-27 | DEF 14A | 2001-06-04 | DEFINITIVE PROXY STATEMENT | k61843def14a.txt |
| 2000-04-11 | DEF 14A | 2000-05-17 | SCHEDULE 14A - DEFINITIVE PROXY STATEMENT | |
| 1999-04-12 | DEF 14A | 1999-05-10 | NOTICE & PROXY | |
| 1998-04-28 | DEF 14A | 1998-05-26 | DEFINITIVE SCHEDULE 14A |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |